Zeqi Zheng

1.3k total citations
48 papers, 786 citations indexed

About

Zeqi Zheng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Zeqi Zheng has authored 48 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Cardiology and Cardiovascular Medicine and 13 papers in Cancer Research. Recurrent topics in Zeqi Zheng's work include MicroRNA in disease regulation (7 papers), Cardiac Fibrosis and Remodeling (6 papers) and Circular RNAs in diseases (5 papers). Zeqi Zheng is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cardiac Fibrosis and Remodeling (6 papers) and Circular RNAs in diseases (5 papers). Zeqi Zheng collaborates with scholars based in China, United States and Australia. Zeqi Zheng's co-authors include Jingtian Peng, Ting Kang, Bingong Li, Menghong Wang, Lijuan Liu, Wan Zhang, Zhe Li, Yong Li, Songping Yu and Ping Yuan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Zeqi Zheng

47 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeqi Zheng China 17 381 191 158 102 89 48 786
Dulguun Amgalan United States 7 549 1.4× 182 1.0× 175 1.1× 168 1.6× 129 1.4× 9 858
Cui Tian China 20 395 1.0× 180 0.9× 134 0.8× 149 1.5× 144 1.6× 31 917
Shengkai Zuo China 16 279 0.7× 124 0.6× 75 0.5× 83 0.8× 71 0.8× 30 613
Ruizheng Shi China 15 308 0.8× 140 0.7× 72 0.5× 91 0.9× 84 0.9× 44 645
Chunpeng Zou China 14 310 0.8× 211 1.1× 75 0.5× 100 1.0× 81 0.9× 35 799
Françoise Maupas‐Schwalm France 15 287 0.8× 160 0.8× 105 0.7× 72 0.7× 52 0.6× 22 686
Haibao Shang China 7 503 1.3× 182 1.0× 89 0.6× 50 0.5× 126 1.4× 12 754
Jingti Deng China 16 434 1.1× 98 0.5× 157 1.0× 51 0.5× 75 0.8× 31 767
Sijia Liang China 15 430 1.1× 67 0.4× 180 1.1× 96 0.9× 97 1.1× 32 754
Zhaoya Liu China 13 306 0.8× 108 0.6× 203 1.3× 104 1.0× 85 1.0× 26 656

Countries citing papers authored by Zeqi Zheng

Since Specialization
Citations

This map shows the geographic impact of Zeqi Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeqi Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeqi Zheng more than expected).

Fields of papers citing papers by Zeqi Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeqi Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeqi Zheng. The network helps show where Zeqi Zheng may publish in the future.

Co-authorship network of co-authors of Zeqi Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Zeqi Zheng. A scholar is included among the top collaborators of Zeqi Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeqi Zheng. Zeqi Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Liang, Xiangqin He, Guoqing Hu, et al.. (2024). A novel mouse model carrying a gene trap insertion into the Hmgxb4 gene locus to examine Hmgxb4 expression in vivo. Physiological Reports. 12(8). e16014–e16014. 1 indexed citations
2.
Liao, Jia, Miaohan Qiu, Xiaojian Feng, et al.. (2024). Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trial. BMC Medicine. 22(1). 410–410. 1 indexed citations
3.
Zhu, Jianbing, Qian Wang, Zeqi Zheng, et al.. (2024). MiR-181a protects the heart against myocardial infarction by regulating mitochondrial fission via targeting programmed cell death protein 4. Scientific Reports. 14(1). 6638–6638. 10 indexed citations
4.
5.
Wang, Qian, Zhaoyang Chen, Junjie Guo, et al.. (2022). Atorvastatin-induced tolerogenic dendritic cells improve cardiac remodeling by suppressing TLR-4/NF-κB activation after myocardial infarction. Inflammation Research. 72(1). 13–25. 8 indexed citations
6.
He, Xiangqin, Kunzhe Dong, Jian Shen, et al.. (2021). Deficiency of the novel high mobility group protein HMGXB4 protects against systemic inflammation-induced endotoxemia in mice. Proceedings of the National Academy of Sciences. 118(7). 8 indexed citations
7.
Wang, Qian, Zhaoyang Chen, Xiaoping Peng, et al.. (2021). Neuraminidase 1 Exacerbating Aortic Dissection by Governing a Pro-Inflammatory Program in Macrophages. Frontiers in Cardiovascular Medicine. 8. 788645–788645. 16 indexed citations
8.
Wang, Liang, Jianqing Zhao, Zeqi Zheng, et al.. (2021). MiR-100-5p regulates cardiac hypertrophy through activation of autophagy by targeting mTOR. Human Cell. 34(5). 1388–1397. 21 indexed citations
9.
Liu, Ting, Liying Hong, Yang Yuan, et al.. (2020). Metformin reduces proteinuria in spontaneously hypertensive rats by activating the HIF-2α-VEGF-A pathway. European Journal of Pharmacology. 891. 173731–173731. 12 indexed citations
10.
Wang, Qian, Zhiliang Zhang, Guoxiang Shi, et al.. (2020). De Winter Syndrome as an Emergency Electrocardiogram sign of ST-Elevation Myocardial Infarction: A Case Report. ESC Heart Failure. 7(6). 4353–4356. 3 indexed citations
11.
Osman, Islam, Liang Wang, Guoqing Hu, Zeqi Zheng, & Jiliang Zhou. (2020). GFAP (Glial Fibrillary Acidic Protein)-Positive Progenitor Cells Contribute to the Development of Vascular Smooth Muscle Cells and Endothelial Cells—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 40(5). 1231–1238. 14 indexed citations
12.
Zheng, Zeqi, et al.. (2020). <p>Anti-Oxidant and Anti-Endothelial Dysfunctional Properties of Nano-Selenium in vitro and in vivo of Hyperhomocysteinemic Rats</p>. International Journal of Nanomedicine. Volume 15. 4501–4521. 32 indexed citations
13.
Wen, Tong, Jinhua Liu, Xiangqin He, et al.. (2019). Transcription factor TEAD1 is essential for vascular development by promoting vascular smooth muscle differentiation. Cell Death and Differentiation. 26(12). 2790–2806. 38 indexed citations
14.
Gong, Li, Yi Xiao, Fan Xia, et al.. (2019). The mevalonate coordinates energy input and cell proliferation. Cell Death and Disease. 10(4). 327–327. 30 indexed citations
15.
16.
Xiong, Wenjun, et al.. (2017). The carboxyl terminus of heat shock protein 70-interacting protein (CHIP) participates in high glucose-induced cardiac injury. Free Radical Biology and Medicine. 106. 339–344. 9 indexed citations
17.
Zheng, Zeqi, et al.. (2017). Molecular mechanisms in microRNA-mediated TRB3 gene and hypertension left ventricular hypertrophy. Experimental and Therapeutic Medicine. 13(5). 1907–1911. 2 indexed citations
18.
Zhang, Jian, et al.. (2015). Protective effects of Notch1 signaling activation against high glucose-induced myocardial cell injury: Analysis of its mechanisms of action. International Journal of Molecular Medicine. 36(3). 897–903. 14 indexed citations
19.
Li, Yong, et al.. (2014). Effect of NRG-1/ErbB Signaling Intervention on the Differentiation of Bone Marrow Stromal Cells Into Sinus Node–like Cells. Journal of Cardiovascular Pharmacology. 63(5). 434–440. 9 indexed citations
20.
Liang, Jia, et al.. (2009). Myeloperoxidase (MPO) and Interleukin-17 (IL-17) Plasma Levels are Increased in Patients with Acute Coronary Syndromes. Journal of International Medical Research. 37(3). 862–866. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dulguun Amgalan Breakdown of academic impact, for papers by Cui Tian Breakdown of academic impact, for papers by Shengkai Zuo Breakdown of academic impact, for papers by Ruizheng Shi Breakdown of academic impact, for papers by Chunpeng Zou Breakdown of academic impact, for papers by Françoise Maupas‐Schwalm Breakdown of academic impact, for papers by Haibao Shang Breakdown of academic impact, for papers by Jingti Deng Breakdown of academic impact, for papers by Sijia Liang Breakdown of academic impact, for papers by Zhaoya Liu
Rankless by CCL
2026